{"PubmedArticleSet": {"PubmedArticle": [{"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "30720863"}, "DateCompleted": {"Year": "2020", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "14"}, "Article": {"@PubModel": "Print-Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1097-0215"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "145", "Issue": "6", "PubDate": {"Year": "2019", "Month": "09", "Day": "15"}}, "Title": "International journal of cancer", "ISOAbbreviation": "Int. J. Cancer"}, "ArticleTitle": "Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China.", "Pagination": {"MedlinePgn": "1517-1528"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1002/ijc.32184"}, "Abstract": {"AbstractText": "To gain more information on the prevalence of germline mutations in BRCA1/2 and PALB2 genes in the Chinese population, and to explore the effects of the mutation status of these genes on clinical outcomes in patients with breast cancer, we performed a screening for BRCA1/2 and PALB2 mutations in a consecutive series of unselected breast cancer patients in the Chinese population. A total of 2,769 cases were enrolled between June 1993 and September 2017. All of the exons and exon-intron boundaries of the BRCA1/2 and PALB2 genes were screened with next-generation sequencing. Of the 2,769 breast cancer patients, BRCA1, BRCA2 and PALB2 mutations accounted for 2.7% (n\u2009=\u200974), 2.7% (n\u2009=\u200976), and 0.9% (n\u2009=\u200924), respectively. The BRCA1 gene had the highest mutation frequency in patients with triple-negative breast cancer (TNBC), which was 9.6% (n\u2009=\u200942), while the BRCA2 gene had the highest mutation frequency in patients with Luminal, which was 3.2% (n\u2009=\u200958). The disease-free survival (DFS) of BRCA1 mutation carriers was significantly lower than that of noncarriers (adjusted HR\u2009=\u20092.20, 95% CI\u2009=\u20091.15-4.18, p\u2009=\u20090.017). The mutation status of the PALB2 gene was significantly associated with the decline in overall survival (OS) (adjusted HR\u2009=\u20098.38, 95% CI\u2009=\u20092.19-32.11, p\u2009=\u20090.002). No significant difference was found between BRCA2 pathogenic mutation carriers and noncarriers. These results demonstrate that BRCA1 mutation status may be associated with a worse disease progression in patients with breast cancer, and women who harbored a PALB2 mutation might be at a higher risk of death due to breast cancer compared to noncarriers.", "CopyrightInformation": "\u00a9 2019 UICC."}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Deng", "ForeName": "Mei", "Initials": "M", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "Department of Radiotherapy, Affiliated Hospital, Guilin Medical University, Guilin, Guangxi, China."}]}, {"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Hui-Hui", "Initials": "HH", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Zhu", "ForeName": "Xuan", "Initials": "X", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Luo", "ForeName": "Meng", "Initials": "M", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Zhang", "ForeName": "Kun", "Initials": "K", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Xu", "ForeName": "Chun-Jing", "Initials": "CJ", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Hu", "ForeName": "Kai-Min", "Initials": "KM", "AffiliationInfo": {"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}}, {"@ValidYN": "Y", "LastName": "Cheng", "ForeName": "Pu", "Initials": "P", "AffiliationInfo": {"Affiliation": "Department of Gynecology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."}}, {"@ValidYN": "Y", "LastName": "Zhou", "ForeName": "Jiao-Jiao", "Initials": "JJ", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Zheng", "ForeName": "Shu", "Initials": "S", "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}, {"@ValidYN": "Y", "LastName": "Chen", "ForeName": "Yi-Ding", "Initials": "YD", "Identifier": {"@Source": "ORCID", "#text": "0000-0002-2263-6275"}, "AffiliationInfo": [{"Affiliation": "Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China."}, {"Affiliation": "The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang, Hangzhou, China."}]}]}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"@UI": "D016428", "#text": "Journal Article"}, {"@UI": "D013485", "#text": "Research Support, Non-U.S. Gov't"}]}, "ArticleDate": {"@DateType": "Electronic", "Year": "2019", "Month": "02", "Day": "22"}}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Int J Cancer", "NlmUniqueID": "0042124", "ISSNLinking": "0020-7136"}, "ChemicalList": {"Chemical": [{"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D014408", "#text": "Biomarkers, Tumor"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "D000076164", "#text": "Fanconi Anemia Complementation Group N Protein"}}, {"RegistryNumber": "0", "NameOfSubstance": {"@UI": "C512790", "#text": "PALB2 protein, human"}}]}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000328", "@MajorTopicYN": "N", "#text": "Adult"}}, {"DescriptorName": {"@UI": "D014408", "@MajorTopicYN": "N", "#text": "Biomarkers, Tumor"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D001943", "@MajorTopicYN": "N", "#text": "Breast Neoplasms"}, "QualifierName": [{"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}, {"@UI": "Q000473", "@MajorTopicYN": "N", "#text": "pathology"}]}, {"DescriptorName": {"@UI": "D018572", "@MajorTopicYN": "N", "#text": "Disease-Free Survival"}}, {"DescriptorName": {"@UI": "D005091", "@MajorTopicYN": "N", "#text": "Exons"}}, {"DescriptorName": {"@UI": "D000076164", "@MajorTopicYN": "N", "#text": "Fanconi Anemia Complementation Group N Protein"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D006580", "@MajorTopicYN": "N", "#text": "Genetic Carrier Screening"}}, {"DescriptorName": {"@UI": "D018095", "@MajorTopicYN": "Y", "#text": "Germ-Line Mutation"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D007438", "@MajorTopicYN": "N", "#text": "Introns"}}, {"DescriptorName": {"@UI": "D008875", "@MajorTopicYN": "N", "#text": "Middle Aged"}}, {"DescriptorName": {"@UI": "D015995", "@MajorTopicYN": "N", "#text": "Prevalence"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "Y", "#text": "BRCA1/2"}, {"@MajorTopicYN": "Y", "#text": "PALB2"}, {"@MajorTopicYN": "Y", "#text": "Breast Cancer"}, {"@MajorTopicYN": "Y", "#text": "Germline mutation"}, {"@MajorTopicYN": "Y", "#text": "clinical outcome"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2018", "Month": "08", "Day": "17"}, {"@PubStatus": "revised", "Year": "2018", "Month": "12", "Day": "30"}, {"@PubStatus": "accepted", "Year": "2019", "Month": "01", "Day": "22"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2020", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "ppublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "30720863"}, {"@IdType": "doi", "#text": "10.1002/ijc.32184"}]}}}, {"MedlineCitation": {"@Status": "MEDLINE", "@Owner": "NLM", "PMID": {"@Version": "1", "#text": "31174498"}, "DateCompleted": {"Year": "2019", "Month": "11", "Day": "20"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"@PubModel": "Electronic", "Journal": {"ISSN": {"@IssnType": "Electronic", "#text": "1471-2407"}, "JournalIssue": {"@CitedMedium": "Internet", "Volume": "19", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jun", "Day": "07"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.", "Pagination": {"MedlinePgn": "551"}, "ELocationID": {"@EIdType": "doi", "@ValidYN": "Y", "#text": "10.1186/s12885-019-5765-3"}, "Abstract": {"AbstractText": [{"@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND", "#text": "Mutated BRCA1/2 genes are associated with hereditary breast and ovarian cancer (HBOC). So far most of the identified BRCA1/2 pathogenic variants are single nucleotide variants (SNVs) or insertions/deletions (Indels). However, large genomic rearrangements (LGRs) such as copy number variants (CNVs) are also playing an important role in HBOC predisposition. Their frequency and spectrum have been well studied in western populations but remain largely unknown for Chinese population."}, {"@Label": "METHODS", "@NlmCategory": "METHODS", "#text": "Peripheral blood samples were collected from 218 unrelated familial breast and/or ovarian cancer (FBOC) patients living in Eastern China. PCR-based Sanger sequencing and panel-based next-generation sequencing (NGS) were performed to detect pathogenic SNVs and Indels in BRCA1/2 genes. For the patients lacking small pathogenic variants, multiplex ligation dependent probe amplification (MLPA) assay was conducted to screen for LGRs."}, {"@Label": "RESULTS", "@NlmCategory": "RESULTS", "#text": "In total, we identified 44 samples (20.1%) carrying small pathogenic variants (26 in BRCA1 and 18 in BRCA2, respectively). Among the rest of 174 samples, five were found carrying novel deleterious LGRs in BRCA1 which are exon5-7dup (1 patient), exon13-14dup (2 patients), and exon1-22del (2 patients). No LGR was found in BRCA2. Overall, LGRs accounted for 16.1% (5/31) of BRCA1 pathogenic variants, and were detected in 2.3% (5/218) of all FBOC patients."}, {"@Label": ", CONCLUSIONS", "@NlmCategory": "UNASSIGNED", "#text": "LGR variants in BRCA1 gene play a significant role in Chinese HBOC patients. MLPA or other similar LGR-detecting methods should be recommended along with nucleotide sequencing as the initial screening approach for Chinese HBOC women."}]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "LastName": "Cao", "ForeName": "Wen-Ming", "Initials": "WM", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Zheng", "ForeName": "Ya-Bing", "Initials": "YB", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Gao", "ForeName": "Yun", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Institute of Cancer Research, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Ding", "ForeName": "Xiao-Wen", "Initials": "XW", "AffiliationInfo": {"Affiliation": "Department of Breast Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Sun", "ForeName": "Yan", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Huang", "ForeName": "Yuan", "Initials": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Lou", "ForeName": "Cai-Jin", "Initials": "CJ", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Pan", "ForeName": "Zhi-Wen", "Initials": "ZW", "AffiliationInfo": {"Affiliation": "Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou, 310022, China."}}, {"@ValidYN": "Y", "LastName": "Peng", "ForeName": "Guang", "Initials": "G", "AffiliationInfo": {"Affiliation": "Department of Clinical Cancer Prevention, the University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA."}}, {"@ValidYN": "Y", "LastName": "Wang", "ForeName": "Xiao-Jia", "Initials": "XJ", "Identifier": {"@Source": "ORCID", "#text": "http://orcid.org/0000-0002-1084-0535"}, "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Zhejiang Cancer Hospital, 1 Banshan East Road, Hangzhou, 310022, China. wxiaojia@yahoo.com."}}]}, "Language": "eng", "GrantList": {"@CompleteYN": "Y", "Grant": [{"GrantID": "81672597", "Agency": "National Natural Science Foundation of China", "Country": null}, {"GrantID": "LY17H160038", "Agency": "Natural Science Foundation of Zhejiang Province, China", "Country": null}, {"GrantID": "2012RCB006", "Agency": "Science and Technology Program offered by Health Bureau of Zhejiang Province, China", "Country": null}, {"GrantID": "2014KYA006", "Agency": "Science and Technology Program offered by Health Bureau of Zhejiang Province, China", "Country": null}, {"GrantID": "2017C03013", "Agency": "Key Research-Development Program of Zhejiang Province", "Country": null}, {"GrantID": "2019C04001", "Agency": "Key Research-Development Program of Zhejiang Province", "Country": null}]}, "PublicationTypeList": {"PublicationType": {"@UI": "D016428", "#text": "Journal Article"}}, "ArticleDate": {"@DateType": "Electronic", "Year": "2019", "Month": "06", "Day": "07"}}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "CitationSubset": "IM", "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"@UI": "D000483", "@MajorTopicYN": "N", "#text": "Alleles"}}, {"DescriptorName": {"@UI": "D019943", "@MajorTopicYN": "N", "#text": "Amino Acid Substitution"}}, {"DescriptorName": {"@UI": "D002681", "@MajorTopicYN": "N", "@Type": "Geographic", "#text": "China"}}, {"DescriptorName": {"@UI": "D005260", "@MajorTopicYN": "N", "#text": "Female"}}, {"DescriptorName": {"@UI": "D015321", "@MajorTopicYN": "Y", "#text": "Gene Rearrangement"}}, {"DescriptorName": {"@UI": "D019398", "@MajorTopicYN": "Y", "#text": "Genes, BRCA1"}}, {"DescriptorName": {"@UI": "D024522", "@MajorTopicYN": "Y", "#text": "Genes, BRCA2"}}, {"DescriptorName": {"@UI": "D020022", "@MajorTopicYN": "Y", "#text": "Genetic Predisposition to Disease"}}, {"DescriptorName": {"@UI": "D023281", "@MajorTopicYN": "Y", "#text": "Genomics"}, "QualifierName": {"@UI": "Q000379", "@MajorTopicYN": "N", "#text": "methods"}}, {"DescriptorName": {"@UI": "D005838", "@MajorTopicYN": "N", "#text": "Genotype"}}, {"DescriptorName": {"@UI": "D061325", "@MajorTopicYN": "N", "#text": "Hereditary Breast and Ovarian Cancer Syndrome"}, "QualifierName": {"@UI": "Q000235", "@MajorTopicYN": "Y", "#text": "genetics"}}, {"DescriptorName": {"@UI": "D006801", "@MajorTopicYN": "N", "#text": "Humans"}}, {"DescriptorName": {"@UI": "D009154", "@MajorTopicYN": "Y", "#text": "Mutation"}}, {"DescriptorName": {"@UI": "D010375", "@MajorTopicYN": "N", "#text": "Pedigree"}}, {"DescriptorName": {"@UI": "D020641", "@MajorTopicYN": "N", "#text": "Polymorphism, Single Nucleotide"}}, {"DescriptorName": {"@UI": "D017422", "@MajorTopicYN": "N", "#text": "Sequence Analysis, DNA"}}]}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"@MajorTopicYN": "N", "#text": "BRCA1"}, {"@MajorTopicYN": "N", "#text": "BRCA2"}, {"@MajorTopicYN": "N", "#text": "Chinese"}, {"@MajorTopicYN": "N", "#text": "Familial breast cancer"}, {"@MajorTopicYN": "N", "#text": "Familial ovarian cancer"}, {"@MajorTopicYN": "N", "#text": "Rearrangement"}]}}, "PubmedData": {"History": {"PubMedPubDate": [{"@PubStatus": "received", "Year": "2017", "Month": "08", "Day": "11"}, {"@PubStatus": "accepted", "Year": "2019", "Month": "05", "Day": "29"}, {"@PubStatus": "entrez", "Year": "2019", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"@PubStatus": "pubmed", "Year": "2019", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"@PubStatus": "medline", "Year": "2019", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}]}, "PublicationStatus": "epublish", "ArticleIdList": {"ArticleId": [{"@IdType": "pubmed", "#text": "31174498"}, {"@IdType": "doi", "#text": "10.1186/s12885-019-5765-3"}, {"@IdType": "pii", "#text": "10.1186/s12885-019-5765-3"}, {"@IdType": "pmc", "#text": "PMC6555923"}]}, "ReferenceList": {"Reference": [{"Citation": "J Natl Cancer Inst. 1999 May 19;91(10):882-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "10340909"}}}, {"Citation": "JAMA. 2006 Mar 22;295(12):1379-88", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "16551709"}}}, {"Citation": "Clin Genet. 2007 Apr;71(4):331-42", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "17470134"}}}, {"Citation": "Cancer Res. 2008 Sep 1;68(17):7006-14", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "18703817"}}}, {"Citation": "Breast Cancer Res Treat. 2010 Sep;123(2):581-5", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20221693"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Jan;125(2):325-49", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20232141"}}}, {"Citation": "Breast Cancer Res Treat. 2010 Nov;124(2):579-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "20617377"}}}, {"Citation": "Breast Cancer Res Treat. 2011 Oct;129(3):1019-20", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21597919"}}}, {"Citation": "Genet Mol Biol. 2009 Jul;32(3):437-46", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "21637503"}}}, {"Citation": "Breast Cancer Res Treat. 2012 May;133(1):273-83", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "22434521"}}}, {"Citation": "J Epidemiol. 2013;23(2):75-84", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "23318652"}}}, {"Citation": "Clin Chem Lab Med. 2014 Aug;52(8):1119-27", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24670361"}}}, {"Citation": "Lancet Oncol. 2014 Jun;15(7):e279-89", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "24872111"}}}, {"Citation": "BMC Cancer. 2014 Sep 01;14:645", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25176351"}}}, {"Citation": "Genet Med. 2015 May;17(5):405-24", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25741868"}}}, {"Citation": "PLoS Genet. 2015 May 06;11(5):e1005228", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "25945795"}}}, {"Citation": "Cancer Genet. 2015 Sep;208(9):448-54", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26271414"}}}, {"Citation": "CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26808342"}}}, {"Citation": "BMC Cancer. 2016 Feb 06;16:64", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "26852015"}}}, {"Citation": "Int J Cancer. 2017 Jul 1;141(1):129-142", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28294317"}}}, {"Citation": "Clin Cancer Res. 2017 Oct 15;23(20):6113-6119", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "28724667"}}}, {"Citation": "Int J Cancer. 2019 Jan 15;144(2):281-289", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "29752822"}}}, {"Citation": "Cancer Res. 1997 Mar 1;57(5):828-31", "ArticleIdList": {"ArticleId": {"@IdType": "pubmed", "#text": "9041180"}}}]}}}]}}